This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Lifshitz Law Firm Announces Investigation Of Dynavax Technologies Corporation, Keynote Systems, Inc., STec, Inc. And Vanguard Health Systems Inc.

Stocks in this article: DVAX KEYN STEC VHS

NEW YORK, June 25, 2013 /PRNewswire/ --

Dynavax Technologies Corporation

Lifshitz Law Firm announces that a class action suit was filed in the United States District Court for the Northern District of California, alleging that Dynavax Technologies Corporation ("Dynavax" or the "Company") (DVAX) issued false and misleading statements to investors between April 26, 2012 and June 10, 2013, inclusive (the "Class Period").  On June 10, 2013, the Company disclosed that in a meeting with the FDA over its biologic license application for hepatitis-B vaccine Heplisav, the FDA expressed that it wanted additional safety data from more patients before approving the drug. The FDA further expressed that analyzing Heplisav for smaller groups of patients did not fully address its concerns and that it would like to see additional safety trials. Moreover, as previously noted by the FDA, the Company disclosed that there were ongoing concerns regarding Dynavax's manufacturing and testing of Heplisav.

For more information, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Keynote Systems, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Keynote Systems, Inc. ("Keynote") (KEYN) to an affiliate of Thoma Bravo, LLC in an all-cash transaction valued at approximately $395 million or $20.00 per share.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to Keynote's shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

sTec, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of sTec, Inc. ("sTec") to Western Digital® Corporation in a transaction valued at approximately $340 million in cash, which equates to $6.85 per share.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to sTec's shareholders.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs